Mirum Pharmaceuticals, Inc. · 1 week ago
Director, Compliance Operations
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. The Director, Compliance Operations is responsible for the support and continual development of the company's compliance program, ensuring ethical and legal obligations are met for various stakeholders.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Lead and manage all aspects of federal and state transparency (Sunshine Act/Open Payments and similar state requirements) and aggregate spend reporting requirements
Monitor and analyze data for trends, anomalies and compliance gaps
Manage ongoing development and execution of Mirum’s risk-based auditing and monitoring program to ensure compliance with applicable laws, regulations and company policies
Work with third-party vendors and internal stakeholders to ensure compliance with state licensing, registration and renewal requirements
Manage continual development and implementation of Mirum’s compliance policies
Champion Company culture in which employees view compliance as aligned with core values and regard it as a key objective in business decisions and process development
Partner with legal, regulatory, finance, quality and other departments to support compliance-related initiatives and resolve operational compliance issues
Assist with ongoing management of training curriculum and healthcare compliance training as needed
Assist with investigations regarding matters of observed, reported or suspected non-compliance and collaborate with functional heads as needed toward implementing necessary corrective actions
Support Privacy initiatives for HIPAA and GDPR compliance as needed
Represent Mirum in industry compliance forums
Participate in ride-long monitoring activities as needed
Qualification
Required
Bachelor's degree required; advanced degree preferred
Minimum 7-10 years of US healthcare compliance experience in a biotech/pharma organization
Demonstrated operational compliance expertise, including hands-on experience with transparency reporting, auditing/monitoring and training
Familiarity with state and federal licensing and registration requirements
Experienced in the development, initiation, maintenance, and enforcement of policies and procedures for the operation of a Compliance Program
Demonstrated collaborations working with senior business leaders, attorneys, law enforcement professionals, and regulators
Experience in supporting investigations and managing the investigative process
Excellent interpersonal skills, ability to develop important relationships with key stakeholders; a solutions-oriented collaborator
Strong knowledge of relevant regulations and related obligations
Good conflict management and negotiation skills
Excellent organizational, communication and leadership skills
Ability to work independently, and analyze complex issues to develop relevant and realistic plans, programs and recommendations
Strong written, verbal, and presentation skills
Willingness to embrace and champion Company core values
Ability to travel on occasion when necessary
Preferred
Rare disease commercial launch experience preferred but not required
Systems implementation/oversight experience preferred
Company
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.
H1B Sponsorship
Mirum Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (2)
2023 (1)
2022 (1)
2021 (1)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$765.5MKey Investors
TCG CrossoverOberland CapitalNew Enterprise Associates
2025-12-19Post Ipo Equity· $68.5M
2025-12-08Post Ipo Equity· $200M
2023-04-12Post Ipo Equity· $275M
Recent News
Labiotech UG
2026-01-08
2026-01-03
Company data provided by crunchbase